These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26851651)

  • 1. Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.
    Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
    Forensic Sci Int; 2016 Mar; 260():95-101. PubMed ID: 26851651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation.
    Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
    Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.
    Scheidweiler KB; Spargo EA; Kelly TL; Cone EJ; Barnes AJ; Huestis MA
    Ther Drug Monit; 2010 Oct; 32(5):628-37. PubMed ID: 20814350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration.
    Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
    Drug Alcohol Depend; 2016 Jun; 163():116-25. PubMed ID: 27114201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.
    Cone EJ; Oyler J; Darwin WD
    J Anal Toxicol; 1997 Oct; 21(6):465-75. PubMed ID: 9323527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma.
    Jenkins AJ; Oyler JM; Cone EJ
    J Anal Toxicol; 1995 Oct; 19(6):359-74. PubMed ID: 8926729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.
    Kolbrich EA; Kim I; Barnes AJ; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
    J Anal Toxicol; 2003 Oct; 27(7):407-11. PubMed ID: 14606993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS).
    Cámpora P; Bermejo AM; Tabernero MJ; Fernández P
    J Anal Toxicol; 2003; 27(5):270-4. PubMed ID: 12908939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.
    Newmeyer MN; Concheiro M; da Costa JL; Flegel R; Gorelick DA; Huestis MA
    Drug Test Anal; 2015 Oct; 7(10):877-83. PubMed ID: 25786659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.
    Desrosiers NA; Milman G; Mendu DR; Lee D; Barnes AJ; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jul; 406(17):4117-28. PubMed ID: 24828976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
    Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
    Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Fluid Testing for Cocaine: Analytical Evaluation of Two Point-of-Collection Drug Screening Devices.
    Scherer JN; Fiorentin TR; Sousa TRV; Limberger RP; Pechansky F
    J Anal Toxicol; 2017 Jun; 41(5):392-398. PubMed ID: 28334841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.
    Anizan S; Bergamaschi MM; Barnes AJ; Milman G; Desrosiers N; Lee D; Gorelick DA; Huestis MA
    Drug Test Anal; 2015 Feb; 7(2):114-20. PubMed ID: 24995604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
    Cooper G; Wilson L; Reid C; Main L; Hand C
    Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of cocaine and benzoylecgonine in rat cerebrospinal fluid after the intravenous administration of cocaine.
    Barbieri EJ; Ferko AP; DiGregorio GJ; Ruch EK
    Life Sci; 1992; 51(22):1739-46. PubMed ID: 1435082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine and benzoylecgonine in saliva, serum, and urine.
    Schramm W; Craig PA; Smith RH; Berger GE
    Clin Chem; 1993 Mar; 39(3):481-7. PubMed ID: 8448861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients.
    Cone EJ
    Forensic Sci Int; 2012 Feb; 215(1-3):88-91. PubMed ID: 21377302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis.
    Moolchan ET; Cone EJ; Wstadik A; Huestis MA; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):458-66. PubMed ID: 11043647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.